Diabetes

In a recent revelation, the weight loss drug Ozempic has been linked to an increased risk of thyroid cancers, The Vaccine Reaction reports. EMA Raises Safety Concerns The European Medicines Agency (EMA) issued a safety signal last month, citing concerns about a possible link to thyroid cancer in...

Dr. Thais Aliabadi, a medical weight loss expert, recently shared her insights on the use of Ozempic, a medication that has gained popularity for its weight loss benefits, Molly Sims reports. Understanding Ozempic Aliabadi, who specializes in obstetrics, gynecology and infertility, and has launched...

The weight loss drug Ozempic, originally a diabetes medication, has been gaining attention for its potential to help users shed pounds. However, the journey with this drug is not without its challenges, as meditation coach and health and wellness content creator, Jen Alico, shared with Newsweek....

Jessica Simpson has refuted rumors suggesting that her significant weight loss was due to the controversial diabetes drug, Ozempic, NZ Herald reports. Denial of Ozempic Use In an interview with Bustle, Simpson denied using Ozempic, a drug known for its weight loss-inducing tendencies and popularity...

Jessica Simpson has refuted rumors suggesting that her significant weight loss was due to the controversial diabetes drug, Ozempic, NZ Herald reports. Denial of Ozempic Use In an interview with Bustle, Simpson denied using Ozempic, a drug known for its weight loss-inducing tendencies and popularity...

For many Canadians, the drug Ozempic has become a game-changer in their fight against obesity and diabetes. One such individual is Edmonton native Susanne Brown, who has found a new lease on life after being prescribed the drug. Global News reports. Ozempic’s Dual Role Originally designed as...

E-commerce platform Shopee has halted the sale of the diabetes drug Ozempic, Free Malaysia Today reports. Shopee has removed the drug listings and taken action against the sellers. The company reminded sellers of their responsibility to comply with local regulations and Shopee’s own...

Novo Nordisk A/S (OTC:NONOF) manufactured diabetes and weight loss drug Ozempic, known scientifically as semaglutide, may have the potential to help break addictions, The Guardian reports. Unexpected Changes Users of the drug have reported a decrease in addictive behaviors, such as smoking and...

In a startling revelation, a new global study warns of a significant surge in diabetes rates worldwide by 2050 if no action is taken, Reuters reports. What’s Happening? The study, led by researchers at the Institute of Health Metrics and Evaluation at the University of Washington, found that...

In a recent report, Bank of America identified the “Disruptive Dozen” emerging technologies that have the most potential to disrupt and revolutionize the healthcare sector over the next years. New therapy for ALS (amyotrophic lateral sclerosis) and a blood test for Alzheimer’s...

Clivi, a Mexico-based diabetes management startup, is aiming to revolutionize healthcare delivery for over 40 million adults with diabetes in Latin America, TechCrunch reports. Addressing a Healthcare Gap With an average of one endocrinologist per nearly 10,000 patients in Mexico, Clivi’s CEO...

This article was originally published on 2Fast4Buds and appears here with permission. Marijuana has been a part of our lives for centuries, even millenniums, however, research on the subject has not been highly active until the last two decades when medical cannabis started gaining popularity....

The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.  The vote was 232 (yes)-193 (no), with 12 Republican members joining their Democratic colleagues to pass the measure. The Affordable...

Viatris Inc's (NASDAQ: VTRS) Mylan will pull one batch of non-interchangeable Semglee, also known as insulin glargine injection.  The Company cited the risk of the label is missing on some prefilled pens contained inside labeled cartons of the drug. The recall doesn't cover...

Medtronic Plc (NYSE: MDT) received a warning letter from the FDA highlighting certain concerns related to medical device quality requirements at the Company's diabetes business headquarters. The Company said that the letter focused on inadequacies in risk assessment, complaint...